MANCINI, MARIA VITTORIA
 Distribuzione geografica
Continente #
EU - Europa 379
NA - Nord America 169
AS - Asia 39
AF - Africa 1
Totale 588
Nazione #
IE - Irlanda 205
US - Stati Uniti d'America 169
IT - Italia 132
CN - Cina 37
FI - Finlandia 29
DE - Germania 5
CH - Svizzera 2
NL - Olanda 2
AT - Austria 1
DK - Danimarca 1
GB - Regno Unito 1
IN - India 1
NG - Nigeria 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 588
Città #
Dublin 205
Ashburn 39
Shanghai 36
Helsinki 29
New York 26
Saluzzo 22
Milan 20
Pavia 14
Trieste 13
Bergamo 12
Chandler 10
Piscataway 8
Turin 8
Camerino 5
Como 4
Rome 4
Washington 4
Seattle 3
Amsterdam 2
Bologna 2
Brembate di Sopra 2
Catania 2
Lodi 2
Los Angeles 2
Pognana Lario 2
Udine 2
Zurich 2
Chelyabinsk 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Lagos 1
Marmirolo 1
Pune 1
San Martino in Strada 1
Sassari 1
Vejle 1
Verona 1
Zhongshan 1
Totale 492
Nome #
Mapping the human genetic architecture of COVID-19 125
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study 29
Mosquitoes can harbour yeasts of clinical significance and contribute to their environmental dissemination 25
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study 24
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK 23
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort 23
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 23
A microsporidian impairs Plasmodium falciparum transmission in Anopheles arabiensis mosquitoes 21
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study 20
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study 18
Wolbachia in Aedes koreicus: Rare Detections and Possible Implications 18
Phylogenomics reveals that asaia symbionts from insects underwent convergent genome reduction, preserving an insecticide-degrading gene 17
Mutual exclusion of Asaia and Wolbachia in the reproductive organs of mosquito vectors 17
Asaia activates immune genes in mosquito eliciting an anti-plasmodium response: Implications in malaria control 16
Mosquitoes can harbour yeasts of clinical significance and contribute to their environmental dissemination 16
Asaia Paratransgenesis in Mosquitoes 15
Inhibition of asaia in adult mosquitoes causes male-specific mortality and diverse transcriptome changes 15
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19 15
Estimating bacteria diversity in different organs of nine species of mosquito by next generation sequencing 15
High Temperature Cycles Result in Maternal Transmission and Dengue Infection Differences between Wolbachia Strains in Aedes aegypti 14
Enhancement of Aedes aegypti susceptibility to dengue by Wolbachia is not supported 14
Establishment of Wolbachia Strain wAlbB in Malaysian Populations of Aedes aegypti for Dengue Control 13
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study 13
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination 12
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England 12
Genome reduction in the mosquito symbiont Asaia 11
Paratransgenesis to control malaria vectors: A semi-field pilot study 10
Wolbachia-Virus interactions and arbovirus control through population replacement in mosquitoes 9
Wolbachia strain wAu efficiently blocks arbovirus transmission in Aedes albopictus 9
Wolbachia strain wAlbB maintains high density and dengue inhibition following introduction into a field population of Aedes aegypti: Wolbachia wAlbB in wild Aedes aegypti 8
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses 6
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells 5
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study 5
Population‐specific responses to developmental temperature in the arboviral vector Aedes albopictus: Implications for climate change 3
High promiscuity among females of the invasive pest species Drosophila suzukii 3
Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model 2
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection 2
Wolbachia strain wAlbB shows favourable characteristics for dengue control use in Aedes aegypti from Burkina Faso 2
Totale 628
Categoria #
all - tutte 3.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023385 0 0 0 141 3 6 15 6 206 1 6 1
2023/2024243 44 25 14 19 20 52 36 9 0 15 9 0
Totale 628